Recent Quotes

My Watchlist

Indicators

Currencies

International

Treasuries

Revolution Medicines, Inc. - Common Stock (NQ:RVMD)

79.02 -0.63 (-0.79%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,381,627
Open	80.29
Bid (Size)	77.01 (100)
Ask (Size)	79.00 (100)
Prev. Close	79.65
Today's Range	77.86 - 80.47
52wk Range	29.17 - 81.97
Shares Outstanding	106,313,250
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Great Rotation: Small Caps Lead the Charge as 2026 Trading Opens

Today 17:11 EST

As the opening bells of 2026 ring across Wall Street, a definitive shift in market leadership is unfolding. In the first trading sessions of the new year, the Russell 2000 index, a benchmark for...

Via MarketMinute

Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock? ↗

Today 2:04 EST

Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock?

Via The Motley Fool

Performance

YTD	N/A	N/A
1 Month	+4.9%	+4.9%
3 Month	+72.9%	+72.9%
6 Month	+108.7%	+108.7%
1 Year	+79.6%	+79.6%

More News

The Small-Cap Renaissance: Why 2026 is the Year of the Russell 2000 and XSU

January 01, 2026

Via MarketMinute

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Up Nearly 400% This Year, Can Oklo Stock Still Rise Higher? ↗

December 10, 2025

Via The Motley Fool

Maplebear, Tower Semiconductor, And Eli Lilly Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 10-Nov. 14): Are the Others in Your Portfolio? ↗

November 16, 2025

Via Benzinga

Revolution Medicines (RVMD) Earnings Transcript ↗

November 05, 2025

Via The Motley Fool

Tango Therapeutics Touts Encouraging Data From Early-Stage Cancer Trial, Raises Capital To Fund Advancement ↗

October 23, 2025

Via Benzinga

Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday? ↗

November 05, 2025

Via Benzinga

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday ↗

October 17, 2025

Via Benzinga

The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly. ↗

October 17, 2025

Via Investor's Business Daily

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times ↗

October 17, 2025

Via Benzinga

'No Need To Sell' Martin Marietta Materials, Cramer Says: 'It's Just A Great Long-Term Hold' ↗

October 17, 2025

Via Benzinga

Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program ↗

October 17, 2025

Via Stocktwits

Analysts Raise Price Targets Following Strong Data From Revolution Medicines' Pancreatic Cancer Drug ↗

September 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 11, 2025

Via Benzinga

Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday ↗

September 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 10, 2025

Via Benzinga

This Parker-Hannifin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗

August 15, 2025

Via Benzinga

Revolution Medicines Inc (NASDAQ:RVMD) Reports Q2 2025 Earnings Miss, Shares Drop 4.5% After-Hours ↗

August 06, 2025

Via Chartmill

This GitLab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

July 15, 2025

Via Benzinga

Revolution Medicines and Summit Therapeutics Enter Into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors With Ivonescimab in RAS Mutant Tumors

June 30, 2025

From Summit Therapeutics Inc.

Via Business Wire

Revolution Medicines To Advance Lead Cancer Drug With $2 Billion In Funds ↗

June 24, 2025

Via Benzinga

Revolution Medicines To Get Up To $2B For Development Of Cancer Drug From Royalty Pharma ↗

June 24, 2025

Via Stocktwits

Frequently Asked Questions

Is Revolution Medicines, Inc. - Common Stock publicly traded?

Yes, Revolution Medicines, Inc. - Common Stock is publicly traded.

What exchange does Revolution Medicines, Inc. - Common Stock trade on?

Revolution Medicines, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Revolution Medicines, Inc. - Common Stock?

The ticker symbol for Revolution Medicines, Inc. - Common Stock is RVMD on the Nasdaq Stock Market

What is the current price of Revolution Medicines, Inc. - Common Stock?

The current price of Revolution Medicines, Inc. - Common Stock is 79.02

When was Revolution Medicines, Inc. - Common Stock last traded?

The last trade of Revolution Medicines, Inc. - Common Stock was at 01/02/26 04:00 PM ET

What is the market capitalization of Revolution Medicines, Inc. - Common Stock?

The market capitalization of Revolution Medicines, Inc. - Common Stock is 8.40B

How many shares of Revolution Medicines, Inc. - Common Stock are outstanding?

Revolution Medicines, Inc. - Common Stock has 8B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.